Your browser doesn't support javascript.
loading
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India.
Moonan, Patrick K; Nair, Sreenivas A; Agarwal, Reshu; Chadha, Vineet K; Dewan, Puneet K; Gupta, Umesh D; Ho, Christine S; Holtz, Timothy H; Kumar, Ajay M; Kumar, Nishant; Kumar, Prahlad; Maloney, Susan A; Mase, Sundari R; Oeltmann, John E; Paramasivan, C N; Parmar, Malik M; Rade, Kiran K; Ramachandran, Ranjani; Rao, Raghuram; Salhorta, Virendra S; Sarin, Rohit; Sarin, Sanjay; Sachdeva, Kuldeep S; Selvaraju, Sriram; Singla, Rupak; Surie, Diya; Tonsing, Jamhoih; Tripathy, Srikanth P; Khaparde, Sunil D.
Afiliación
  • Moonan PK; Global Tuberculosis Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Nair SA; Stop TB Partnership, Geneva, Switzerland.
  • Agarwal R; CDC India Country Office, U.S. Centers for Disease Control and Prevention, New Delhi, India.
  • Chadha VK; Department of Epidemiology and Research, National Tuberculosis Institute, Bangalore, India.
  • Dewan PK; Global Health, Bill and Melinda Gates Foundation, Seattle, USA.
  • Gupta UD; National JALMA Institute for Leprosy and other Mycobacterial Diseases, Agra, India.
  • Ho CS; CDC India Country Office, U.S. Centers for Disease Control and Prevention, New Delhi, India.
  • Holtz TH; CDC India Country Office, U.S. Centers for Disease Control and Prevention, New Delhi, India.
  • Kumar AM; Department of Research, International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Kumar N; Revised National Tuberculosis Control Programme, India Ministry of Health and Family Welfare, New Delhi, India.
  • Kumar P; National Tuberculosis Institute, Bangalore, India.
  • Maloney SA; Global Tuberculosis Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Mase SR; WHO India Country Office, World Health Organization, New Delhi, India.
  • Oeltmann JE; Global Tuberculosis Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Paramasivan CN; India Country Office, Foundation for Innovative New Diagnostics, New Delhi, India.
  • Parmar MM; India Country Office, World Health Organization, New Delhi, India.
  • Rade KK; India Country Office, World Health Organization, New Delhi, India.
  • Ramachandran R; India Country Office, World Health Organization, New Delhi, India.
  • Rao R; Revised National Tuberculosis Control Programme, India Ministry of Health and Family Welfare, New Delhi, India.
  • Salhorta VS; Revised National Tuberculosis Control Programme, India Ministry of Health and Family Welfare, New Delhi, India.
  • Sarin R; National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
  • Sarin S; India Country Office, Foundation for Innovative New Diagnostics, New Delhi, India.
  • Sachdeva KS; Revised National Tuberculosis Control Programme, India Ministry of Health and Family Welfare, New Delhi, India.
  • Selvaraju S; Department of Epidemiology, National Institute for Research in Tuberculosis, Chennai, India.
  • Singla R; Department of Tuberculosis and Respiratory Diseases, National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India.
  • Surie D; Global Tuberculosis Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Tonsing J; South-east Asia Office, International Union Against Tuberculosis and Lung Disease, New Delhi, India.
  • Tripathy SP; National Institute for Research in Tuberculosis, Chennai, India.
  • Khaparde SD; Revised National Tuberculosis Control Programme, India Ministry of Health and Family Welfare, New Delhi, India.
BMJ Glob Health ; 3(5): e001135, 2018.
Article en En | MEDLINE | ID: mdl-30364389
ABSTRACT
The End TB Strategy envisions a world free of tuberculosis-zero deaths, disease and suffering due to tuberculosis by 2035. This requires reducing the global tuberculosis incidence from >1250 cases per million people to <100 cases per million people within the next two decades. Expanding testing and treatment of tuberculosis infection is critical to achieving this goal. In high-burden countries, like India, the implementation of tuberculosis preventive treatment (TPT) remains a low priority. In this analysis article, we explore potential challenges and solutions of implementing TPT in India. The next chapter in tuberculosis elimination in India will require cost-effective and sustainable interventions aimed at tuberculosis infection. This will require constant innovation, locally driven solutions to address the diverse and dynamic tuberculosis epidemiology and persistent programme monitoring and evaluation. As new tools, regimens and approaches emerge, midcourse adjustments to policy and practice must be adopted. The development and implementation of new tools and strategies will call for close collaboration between local, national and international partners-both public and private-national health authorities, non-governmental organisations, research community and the diagnostic and pharmaceutical industry. Leading by example, India can contribute to global knowledge through operational research and programmatic implementation for combating tuberculosis infection.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BMJ Glob Health Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BMJ Glob Health Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM